Reply letter to “COVID-19 and Recurrent Status Epilepticus"
Main Article Content
Keywords
status epilepticus, SARS-CoV-2 infection, neuroinflammation
References
1. Pauletto G., Nilo A., Deana C., Verriello L., Del Negro I., Lettieri C., Vetrugno L., Valente M., Gigli G.L. Recurrent Status Epilepticus and SARS-CoV-2 infection: the perfect storm. Acta Biomedica 2021; Vol 92, N.5: e2021208
2. C. Deana, L. Verriello, G. Pauletto, F. Corradi, F. Forfori, G. Cammarota, E. Bigani, L. Vetrugno, T. Bove. Insight into neurological dysfunction in critically ill COVID-19 patients. Trends in Anaesthesia and Critical Care, 2020.
3. A. Vezzani, R. Dingledine and A. O. Rossetti. Immunity and inflammation in Status Epilepticus and its sequelae: possibility for therapeutic application. Expert Rev Neurother 2015; 15(9): 1081- 1092. doi: 10.1586/14737175.2015.1079130
4. M. Belluzzo, A. Nilo, M. Valente, G. L. Gigli. New-onset status epilepticus in SARS-CoV-2 infection: a case series. Neurol Sci. 2021 Aug 16: 1-6. doi: 10.1007/s10072-021-05536-0
2. C. Deana, L. Verriello, G. Pauletto, F. Corradi, F. Forfori, G. Cammarota, E. Bigani, L. Vetrugno, T. Bove. Insight into neurological dysfunction in critically ill COVID-19 patients. Trends in Anaesthesia and Critical Care, 2020.
3. A. Vezzani, R. Dingledine and A. O. Rossetti. Immunity and inflammation in Status Epilepticus and its sequelae: possibility for therapeutic application. Expert Rev Neurother 2015; 15(9): 1081- 1092. doi: 10.1586/14737175.2015.1079130
4. M. Belluzzo, A. Nilo, M. Valente, G. L. Gigli. New-onset status epilepticus in SARS-CoV-2 infection: a case series. Neurol Sci. 2021 Aug 16: 1-6. doi: 10.1007/s10072-021-05536-0